3 hours ago
Obesity biotech Kalohexis files confidential IPO
Just weeks after forming as a spinout from Endevica Bio, obesity drug developer Kalohexis has filed for an IPO, whilst initially keeping the details of its offer under wraps. Terms of the offering have not yet been determined, said the company in... Read more.
More from pharmaphorum
Owner: Eversana Co. (Greg Skalicky & Jeff Park Presidents, Mark Thierer CEO)
Owner: Eversana Co. (Greg Skalicky & Jeff Park Presidents, Mark Thierer CEO)
Owner: Eversana Co. (Greg Skalicky & Jeff Park Presidents, Mark Thierer CEO)
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
